Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
Background: Nosocomial pneumonia is a major health and economic burden globally. Multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacteria are the most common causative pathogens in critically-ill patients. Polymyxin B is a salvage therapy for MDR Gram-negative pathogens;...
Main Authors: | Huihui Zeng, Zihang Zeng, Xianglong Kong, Hongliang Zhang, Ping Chen, Hong Luo, Yan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.579069/full |
Similar Items
-
Effectiveness, nephrotoxicity, and therapeutic drug monitoring of polymyxin B in nosocomial pneumonia among critically ill patients
by: Qinghua Ye, et al.
Published: (2022-05-01) -
Effect of Different Dosage Frequency of Polymyxin B on Rat Nephrotoxicity
by: Sun W, et al.
Published: (2021-02-01) -
Nephrotoxicity and Efficacy Assessment of Polymyxin B Use in Renal Transplant Patients
by: Wen YX, et al.
Published: (2022-01-01) -
Transcriptomic Responses to Polymyxin B and Analogues in Human Kidney Tubular Cells
by: Mengyao Li, et al.
Published: (2023-02-01) -
Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study
by: Ritesh Aggarwal, et al.
Published: (2018-03-01)